Bank of America, Royal Bank of Canada, and Truist Financial raised price targets for Agios Pharmaceuticals on July 31, 2026.
3 reports, 1 independent
Updated Oct 10
Gone quiet
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bank of America, Royal Bank of Canada, and Truist Financial raised price targets for Agios Pharmaceuticals on July 31, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Truist Financial lowered its price target for Agios Pharmaceuticals.1 source
Three financial firms raised price targets for Agios Pharmaceuticals.1 source
Keep exploring
The entities involved
-
Agios Pharmaceuticals
a public American pharmaceutical company
Nothing else this week.